EUVIMEDEUVIMED entdecken
Open Access

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery

Benedette Cuffari

Journal of Medical Internet Research · 29.05.2026 · 28 · e101366-e101366

DOI: 10.2196/101366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 29.05.2026. Verfasst von Benedette Cuffari. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Trials as Topic, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceClinical Trials as TopicDrug DiscoveryHumansDrug Design

Stichwörter der Autor:innen

artificial intelligence in drug discoverycomputational drug discoveryde novo drug designgenerative chemistrymachine learning in drug design

Zitieren

APA

Cuffari, B. (2026). From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research, 28, e101366-e101366. https://doi.org/10.2196/101366

Vancouver

Cuffari B. From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research. 2026;28:e101366-e101366. doi:10.2196/101366

BibTeX
@article{Cuffari2026,
  author = {Cuffari, Benedette},
  title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e101366--e101366},
  doi = {10.2196/101366}
}
Kostenlos starten →